Is the Enzyme ACMSD a Novel Therapeutic Target in Parkinson’s Disease?
Keerthi Thirtamara Rajamani(Cornell University), Lena Brundin(Van Andel Institute), Martha L. Escobar Galvis(Van Andel Institute), Patrik Brundin(Roche (Switzerland)), Viviane Labrie(Van Andel Institute), Peipei Li(Zhengzhou University)
Cited by 36
Related Papers
Mesenchymal glioma stem cells are maintained by activated glycolytic metabolism involving aldehyde dehydrogenase 1A3
|Proceedings of the National Academy of Sciences|2013|644
Transgenic mice expressing a Huntington’s disease mutation are resistant to quinolinic acid-induced striatal excitotoxicity
|Proceedings of the National Academy of Sciences|1999|229
Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term
|Acta Neuropathologica|2017|224
A deadly spread: cellular mechanisms of α-synuclein transfer
|Cell Death and Differentiation|2011|157
“Latent” infection with Toxoplasma gondii: Association with trait aggression and impulsivity in healthy adults
|Journal of Psychiatric Research|2014|124